The Danish drugmaker will start selling a pill version of its Wegovy weight-loss medicine in January, after [securing ...

As Novo Nordisk’s FDA-approved Wegovy pill sets up a high-stakes comeback, should NVO be back on investors’ radar now?

Major stock indexes ended higher for a fourth straight session Tuesday, with the S&P 500 setting a fresh closing record, ...

But Eli Lilly's Zepbound is best in class. Zepbound caused greater average weight loss than Wegovy in a head-to-head study. And through the first nine months of 2025, Zepbound generated $9.3 billion ...

Asian shares were mixed Thursday in thin holiday trading, with most markets in the region and elsewhere closed for ...